AHFS Drug Information
8 September 2026
AHFS Drug Information
This update contains 10 new monographs and 6 revised monographs….
AHFS Drug Information
Evaluative evidence-based guidance for safe and effective drug therapy
Published by the American Society of Health-System Pharmacists (ASHP), AHFS Drug Information is a dependable, comprehensive, and objective database for drug products approved by the FDA.
The American Hospital Formulary Service (AHFS) drug information database is maintained and updated continuously throughout the year.
The inclusion of evidence-based data on licensed and unlicensed drug use makes this a valuable reference for health professionals seeking to provide their patients with safe and effective therapy.
- 96k+
- Uniquely cited references
- 62k+
- Supporting evidence sources
- 500+
- Peer reviews
- 64+
- Years since first published
Ensure safe and effective medication use
Highly detailed monographs to support clinical practice
Critical, evidence-based evaluation of relevant clinical data
Compiled without influence from manufacturers, insurers and regulators
Full spectrum of drug therapy including dose, use, pharmacology, safety and pharmacokinetics
Covers licensed and off-licensed usage of medicines
Comprehensive database of prescription and over-the-counter drugs, alternative therapies and supplements
Expertly curated content from AHSP
Latest knowledge updates
8 September 2026
AHFS Drug Information
This update contains 10 new monographs and 6 revised monographs.
New monographs: Acetaminophen and Codeine Phosphate; Acetaminophen and Ibuprofen; Butalbital and Acetaminophen; Butalbital, Acetaminophen, and Caffeine; Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate; Ensitrelvir; Hydrocodone Bitartrate and Acetaminophen; Oxycodone and Acetaminophen; Tebipenem pivoxil; Veligrotug-vvze.
Revised monographs: Almotriptan Malate; Amphotericin B; Avutometinib Potassium and Defactinib Hydrochloride; Darunavir Ethanolate and Cobicistat; Depemokimab-ulaa; Esmolol Hydrochloride; Frovatriptan Succinate; Imiglucerase; Lerodalcibep-liga; Meloxicam; Panitumumab; Revumenib Citrate; riTUXimab; Tezepelumab-ekko; traMADol Hydrochloride.
Click to close
11 August 2026
AHFS Drug Information
This update contains 10 new monographs and 32 revised monographs….
11 August 2026
AHFS Drug Information
This update contains 10 new monographs and 32 revised monographs.
New monographs: Atenolol and Chlorthalidone; Baxdrostat; Bulevirtide Acetate-gmod; Cefepime Hydrochloride and Zidebactam Dihydrate; Dolutegravir Sodium, Lamivudine, and Tenofovir Disoproxil Fumarate; Naproxen and Esomeprazole; Pivekimab Sunirine-pvzy; Sonrotoclax; SUMAtriptan Succinate and Naproxen Sodium; Tramadol Hydrochloride and Acetaminophen.
Revised monographs: Acetaminophen; Adenovirus Vaccine Live Oral; Apremilast; Arsenic Trioxide; Avatrombopag Maleate; Belantamab Mafodotin-blmf; Cetirizine Hydrochloride; Coagulation Factor IX (Recombinant); Darolutamide; DOBUTamine Hydrochloride; Dupilumab; Elinzanetant; Escitalopram Oxalate; Etripamil; Granisetron; Ketotifen Fumarate; Landiolol Hydrochloride; Levocetirizine Dihydrochloride; Mirdametinib; Mitapivat Sulfate; Modafinil; Nalmefene Hydrochloride; Niraparib Tosylate; Nirmatrelvir and Ritonavir; Palbociclib; Pentazocine Hydrochloride and Naloxone Hydrochloride; Plozasiran Sodium; Ramipril; Roflumilast (Topical); Sulopenem Etzadroxil and Probenecid; Tick-borne Encephalitis Vaccine; Vasopressin.
Click to close
7 July 2026
AHFS Drug Information
This update contains 5 new monographs and 26 revised monographs….
7 July 2026
AHFS Drug Information
This update contains 5 new monographs and 26 revised monographs.
New monographs: Ceftobiprole Medocaril Sodium; Ciltacabtagene Autoleucel; Doravirine and Islatravir; Lunsotogene Parvec-cwha; Vepdegestrant.
Revised monographs: Amiodarone Hydrochloride; Apixaban; Aprepitant, Fosaprepitant Dimeglumine; Citalopram Hydrobromide; Dabrafenib Mesylate; Daptomycin; Doxecitine and Doxribtimine; Elranatamab-bcmm; Emapalumab; FLUoxetine Hydrochloride; Golimumab; Guselkumab; HYDROcodone Bitartrate; Ipilimumab; Isoproterenol Hydrochloride; Linezolid; Lumateperone Tosylate; Sibeprenlimab-szsi; Succinylcholine Chloride; Suzetrigine; Trastuzumab; Trofinetide; Vecuronium Bromide; Ziftomenib; Zolbetuximab-clzb.
Click to close
9 June 2026
AHFS Drug Information
This update contains 7 new monographs and 49 revised monographs….
9 June 2026
AHFS Drug Information
This update contains 7 new monographs and 49 revised monographs.
New monographs: Icotrokinra Hydrochloride; Insulin icodec-abae; Linerixibat; Marnetegragene autotemcel; Orforglipron Calcium; Relacorilant; Tividenofusp Alfa-eknm.
Revised monographs: Aficamten; Atogepant; Atracurium Besylate; Avacopan; Berotralstat Dihydrochloride; Bosentan; Cabozantinib S-malate; Cisatracurium Besylate; Collagenase Clostridium Histolyticum; COVID-19 Vaccine, Adjuvanted (Novavax) (2025-2026 Formula); COVID-19 Vaccine, mRNA (Moderna) (2025-2026); COVID-19 Vaccine, mRNA (Pfizer-BioNTech) (2025-2026 Formula); Datopotamab Deruxtecan-dlnk; Dordaviprone Hydrochloride; Eflapegrastim-xnst; Enalapril; Enzalutamide; Eteplirsen; Evinacumab-dgnb; Fidaxomicin; Influenza Vaccine Inactivated; Influenza Vaccine Live Intranasal; Influenza Vaccine Recombinant; Insulin Aspart; Insulin Lispro; Ipratropium Bromide (EENT); Lisinopril; Lisocabtagene Maraleucel; Meningococcal Groups A, B, C, W, and Y Vaccine; Mirdametinib; Moexipril Hydrochloride; Odevixibat; Olaparib; Olezarsen Sodium; Paromomycin Sulfate; Pegcetacoplan (Immunomodulatory Agent); Penpulimab-kcqx; Pivmecillinam Hydrochloride; Plozasiran Sodium; Promethazine Hydrochloride (Sedative/Antiemetic); RABEprazole Sodium; Remestemcel-L-rknd; Resmetirom; Respiratory Syncytial Virus Vaccine; Respiratory Syncytial Virus Vaccine (mRNA); Respiratory Syncytial Virus Vaccine, Adjuvanted; Retifanlimab-dlwr; Sotatercept-csrk; Tamoxifen Citrate; Telmisartan; Zanidatamab-hrii.
Click to close
13 May 2026
AHFS Drug Information
This update contains 4 new monographs and 43 revised monographs….
13 May 2026
AHFS Drug Information
This update contains 4 new monographs and 43 revised monographs.
New monographs: Difamilast; Milsaperidone; Navepegritide; Pegzilarginase-nbln.
Revised monographs: Antihemophilic Factor (Recombinant), Single chain; Benazepril Hydrochloride; Brexanolone; Colesevelam Hydrochloride; Concizumab-mtci; Desmopressin Acetate; DOPamine Hydrochloride; Elagolix Sodium, Estradiol, and Norethindrone Acetate; Ertapenem Sodium; Estradiol; Estrogen-Progestin Combinations; Estrogens, Conjugated, USP; Estrogens, Esterified; Estropipate; Fam-Trastuzumab Deruxtecan-nxki; Fosinopril Sodium; Insulin Glulisine; Insulin Human; levOCARNitine; Levodopa/Carbidopa; Lonapegsomatropin-tcgd; Meropenem; Meropenem and Vaborbactam; metroNIDAZOLE (Systemic); metroNIDAZOLE (Topical); Nerandomilast; Nicotine; NIFEdipine; niMODipine; Nintedanib Esylate; Nipocalimab-aahu; Ondansetron Hydrochloride; Perindopril Erbumine; Plazomicin Sulfate; Pramlintide Acetate; Quinapril Hydrochloride; Quinupristin and Dalfopristin; Ruxolitinib Phosphate (Topical); Selumetinib Sulfate; Tarlatamab-dlle; Tazemetostat Hydrobromide; Trandolapril; Valoctocogene Roxaparvovec-rvox; Verapamil Hydrochloride.
Click to close
14 April 2026
AHFS Drug Information
This update contains 7 new monographs and 32 revised monographs….
14 April 2026
AHFS Drug Information
This update contains 7 new monographs and 32 revised monographs.
New monographs: Carbachol and Brimonidine Tartrate; Copper Histidinate; Narsoplimab-wuug; Tradipitant.
Revised monographs: amLODIPine; Captopril; Cefuroxime; Clevidipine; cloNIDine; Codeine; Corticotropin, Repository; Cosibelimab-ipdl; Dasiglucagon Hydrochloride; Digoxin; dilTIAZem Hydrochloride; Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed/Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed; Donidalorsen Sodium; Elamipretide Hydrochloride; Eptifibatide; Felodipine; Flunisolide (Oral Inhalation); Furosemide; guanFACINE Hydrochloride; Haemophilus b Vaccine; Heparin Sodium; Hepatitis B Vaccine; Imlunestrant Tosylate; Lisinopril; Lisocabtagene Maraleucel; Losartan Potassium; MetroNIDAZOLE (systemic); Nemolizumab-ilto; NIFEdipine; Olmesartan Medoxomil; Paltusotine Hydrochloride; Pomalidomide; PONATinib Hydrochloride; Pralsetinib; Ribavirin; Risankizumab-rzaa; Sacubitril and Valsartan; SITagliptin; Sodium Nitroprusside; Tetanus and Diphtheria Toxoids Adsorbed; Tirofiban Hydrochloride; Varenicline Tartrate; Verapamil Hydrochloride; Zanubrutinib; Zenocutuzumab-zbco.
Click to close
Request access today
Access AHFS Drug Information through MedicinesComplete today.
Contact us now for pricing and access information.
Related insights
Upcoming Webinar
24 September 2026 – 14:00 BST (13:00 UTC, 09:00 EST)
Minimising prescribing and dosing errors: strategies for patient safety
The health profession is not just who we serve, it’s where we belong
Opens in a new window